Clinical Trials Browser

Anatomic Stage II Breast Cancer AJCC v8 × Ado-Trastuzumab Emtansine × 90 days × Clear all

NCT04266249 2026-05-05

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

Phase 2 Active not recruiting

Anatomic Stage II Breast Cancer AJCC v8